{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:49:14Z","timestamp":1769550554175,"version":"3.49.0"},"reference-count":23,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2004,10,12]],"date-time":"2004-10-12T00:00:00Z","timestamp":1097539200000},"content-version":"vor","delay-in-days":4302,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[1993,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after injection in all 15 patients. Patients were then injected with botulinum toxin type F (botox F) in the same muscles that had been injected with botox A. Ten of the 15 improved after botox F injections, including 9 of the 12 patients who had improved with type A toxin. Six of 9 patients with pain had improvement in pain after botox F injections. Patients reported similar improvement with type F and type A toxins, but duration of benefit was \u02dc3 months with type A and \u02dc1 month with type F. Botox F is an effective treatment for torticollis in patients who are immune to botox A. The usefulness of type F toxin, however, is limited by short duration of benefit.<\/jats:p>","DOI":"10.1002\/mds.870080411","type":"journal-article","created":{"date-parts":[[2004,12,31]],"date-time":"2004-12-31T10:07:21Z","timestamp":1104487641000},"page":"479-483","source":"Crossref","is-referenced-by-count":78,"title":["Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A"],"prefix":"10.1002","volume":"8","author":[{"given":"Paul E.","family":"Greene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Fahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,12]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.616"},{"issue":"1","key":"e_1_2_1_3_2","first-page":"271","article-title":"Double\u2010blind controlled study of botulinum toxin for blepharospasm","volume":"35","author":"Fahn S","year":"1985","journal-title":"Neurology"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92070-2"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.37.4.616"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.1.80"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.8.1213"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.8.640"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060210"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.9.813"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199106000-00010"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/000348948909800202"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.52.3.355"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870060110"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870020402"},{"key":"e_1_2_1_16_2","first-page":"181","article-title":"Production of circulating antibodies to botulinum\u2010A toxin in patients receiving repeated injections for dystonia","volume":"23","author":"Tsui JK","year":"1988","journal-title":"Ann Neurol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/jcm.27.8.1906-1908.1989","article-title":"Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid","volume":"27","author":"Siegel LS","year":"1989","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/am.29.5.598-603.1975","article-title":"Purification and properties of Clostridium botulinum type F toxin","volume":"29","author":"Yang KH","year":"1975","journal-title":"Appl Microbiol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(85)90342-4"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260516"},{"key":"e_1_2_1_21_2","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed LJ","year":"1938","journal-title":"Am J Hyg"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-3898-0_12"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1128\/jcm.26.11.2351-2356.1988","article-title":"Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme\u2010linked immunosorbent assay","volume":"26","author":"Siegel LS","year":"1988","journal-title":"J Clin Microbiol"},{"key":"e_1_2_1_24_2","first-page":"113","volume-title":"Botulism: proceedings of a symposium","author":"Cardella MA","year":"1964"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.870080411","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.870080411","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:23:29Z","timestamp":1760959409000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.870080411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,1]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,1]]}},"alternative-id":["10.1002\/mds.870080411"],"URL":"https:\/\/doi.org\/10.1002\/mds.870080411","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,1]]}}}